Frontlight ResearchEarly access
Trial site
Azienda USL IRCCS Di Reggio Emilia
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Follicular lymphoma1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- IRCCS Istituto Nazionale Tumori Fondazione Pascale2 trials
- AstraZeneca1 trial
- Olema Pharmaceuticals, Inc.1 trial
Running trials
Not yet recruiting
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Follicular lymphoma1 recruiting
- Lung cancer1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026